Total Funding
41
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
39494
Better Therapeutics develops prescription software for treating cardiometabolic diseases.
Acquired by 
Click Therapeutics
Kevin Appelbaum: Co-founder, CEO & Board DirectorPast Role: American College of Lifestyle Medicine, Member- David Perry: Chairman and Co-founderPast Role: Indigo, President, CEO, and Director
About the Company
Better Therapeutics discovers, develops, and commercializes prescription digital therapeutics for the treatment of cardiovascular and metabolic diseases. They use clinically-validated, FDA-regulated software to change the behaviors that cause these diseases to aid in quality of life, reducing the need for medications, and lowering costs. Their
products deliver digital behavioral therapy that integrates neuroscience, lifestyle medicine, and explainable AI into a physician-prescribed mobile medical app and uses patient-generated data to inform clinical decision-making and improve treatment outcomes. Their current product pipeline includes therapeutic candidates for the treatment of type 2 diabetes, hypertension, and dyslipidemia.
